Edition:
United States

Insider Trading: AcelRx Pharmaceuticals Inc (ACRX.O)

ACRX.O on Consolidated Issue listed on NASDAQ Global Market

3.20USD
22 Sep 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$3.20
Open
$3.20
Day's High
$3.25
Day's Low
$3.15
Volume
279,776
Avg. Vol
1,054,897
52-wk High
$4.08
52-wk Low
$1.95

All Insider Trades
Trading Date Name Title Type Shares Traded Price
10 Sep 2017

Asadorian (Raffi)

Chief Financial Officer Buy 7,000 $3.24
23 Aug 2017

Edwards (Mark G)

Director Buy 4,800 $3.03
23 Aug 2017

Angotti Vincent J

Chief Executive Officer Buy 15,000 $3.00
21 Aug 2017

Palmer (Pamela P)

Officer and Director Buy 10,000 $2.95
21 Aug 2017

Edwards (Mark G)

Director Buy 200 $2.90
18 Jun 2017

PERCEPTIVE ADVISORS L L C

Beneficial Owner of More than 10% Class Sell 875,000 $2.40
9 Apr 2017

Hamel (Lawrence G)

Officer Buy 9,122 $1.20
9 Apr 2017

Hamel (Lawrence G)

Officer Buy 6,879 $0.00
28 Sep 2016

PERCEPTIVE ADVISORS L L C

Beneficial Owner of More than 10% Class Sell 97,200 $3.88
27 Sep 2016

PERCEPTIVE ADVISORS L L C

Beneficial Owner of More than 10% Class Sell 119,300 $3.96
14 Sep 2016

PERCEPTIVE ADVISORS L L C

Beneficial Owner of More than 10% Class Sell 276,927 $3.73
14 Sep 2016

PERCEPTIVE ADVISORS L L C

Beneficial Owner of More than 10% Class Sell 115,923 $3.63
12 May 2016

Rosen (Howard B)

Chief Executive Officer Buy 10,206 $3.26
11 May 2016

Edwards (Mark G)

Director Buy 5,000 $3.05
10 May 2016

Edwards (Mark G)

Director Buy 5,000 $3.15
9 May 2016

Edwards (Mark G)

Director Buy 5,000 $3.25
17 Nov 2015

PERCEPTIVE ADVISORS L L C

Beneficial Owner of More than 10% Class Sell 42,300 $5.35
16 Nov 2015

PERCEPTIVE ADVISORS L L C

Beneficial Owner of More than 10% Class Sell 133,900 $5.36
5 Nov 2015

PERCEPTIVE ADVISORS L L C

Beneficial Owner of More than 10% Class Sell 17,100 $4.47
4 Nov 2015

PERCEPTIVE ADVISORS L L C

Beneficial Owner of More than 10% Class Sell 75,000 $4.62

Institutional Holders

% Shares Owned: 39.71%
# of Holders: 85
Total Shares Held: 18,019,544
3 Mo. Net Change: -3,904,886
# New Positions: 13
# Closed Positions: 28
# Increased Positions: 28
# Reduced Positions: 52
# Net Buyers: -24

Officers & Directors

Name Age Since Current Position

Adrian Adams

64 2013 Independent Chairman of the Board

Richard King

52 2015 President

Vincent Angotti

48 2017 Chief Executive Officer

Raffi Asadorian

47 2017 Chief Financial Officer

Pamela Palmer

52 2005 Chief Medical Officer, Director

Badri Dasu

52 2007 Chief Engineering Officer

Lawrence Hamel

63 2006 Chief Development Officer

Jane Wright-Mitchell

46 2014 Chief Legal Officer

Richard Afable

61 2013 Director

Howard Rosen

59 2017 Director

Mark Edwards

57 2011 Independent Director

Stephen Hoffman

62 2010 Independent Director

Mark Wan

49 2006 Independent Director

Brian Korb

2015 IR Contact Officer